[go: up one dir, main page]

Porreca et al., 2003 - Google Patents

Novel Mu, Delta, and Kappa Agonists: Potential for Development of Novel Analgesic Agents

Porreca et al., 2003

Document ID
10986517122435704189
Author
Porreca F
Hruby V
Publication year
Publication venue
Pain

External Links

Snippet

Current opioid analgesics such as morphine are known to exert their specific pharmacological effects through the mu (µ) opioid receptor. Although powerful and effective pain killers, opioid µ-agonists have many undesirable side effects including analgesic …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Similar Documents

Publication Publication Date Title
Janecka et al. Opioid receptors and their ligands
Ananthan Opioid ligands with mixed μ/δ opioid receptor interactions: an emerging approach to novel analgesics
Dietis et al. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
Schiller 6 Development of Receptor-Specific Opioid Peptide Analogues
Schiller et al. The TIPP opioid peptide family: development of δ antagonists, δ agonists, and mixed μ agonist/δ antagonists
Hruby et al. Conformation–activity relationships of opioid peptides with selective activities at opioid receptors
US5610271A (en) Kappa receptor selective opioid peptides
Arttamangkul et al. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the “address” sequence
Janecka et al. Conformationally restricted peptides as tools in opioid receptor studies
Anand et al. Modulation of opioid receptor ligand affinity and efficacy using active and inactive state receptor models
De Marco et al. Strategies to improve bioavailability and in vivo efficacy of the endogenous opioid peptides endomorphin-1 and endomorphin-2
Ballet et al. Multiple ligands in opioid research
Gisemba et al. Conformational constraint between aromatic residue side chains in the “message” sequence of the peptide arodyn using ring closing metathesis results in a potent and selective kappa opioid receptor antagonist
Kawasaki et al. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs
Proteau-Gagné et al. Exploring the backbone of enkephalins to adjust their pharmacological profile for the δ-opioid receptor
EP0853484B1 (en) Novel mu opioid receptor ligands: agonists and antagonists
Porreca et al. Novel Mu, Delta, and Kappa Agonists: Potential for Development of Novel Analgesic Agents
Schiller et al. Opioid peptide analogs with novel activity profiles as potential therapeutic agents for use in analgesia
Wang et al. Differential antinociceptive effects of intrathecal administration of C‐terminal esterified endomorphin‐2 analogues in mice
Davis Opioid receptor targeting ligands for pain management: a review and update
Weltrowska et al. N‐Methylated cyclic enkephalin analogues retain high opioid receptor binding affinity
Ioja et al. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles
Janecka et al. Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues-selective μ-opioid receptor ligands
Joshi Synthesis and biological evaluation of dynorphin analogs and, Caco-2 permeability of opioid macrocyclic tetrapeptides
Schlechtingen et al. Structure–activity relationships of dynorphin analogs substituted in positions 2 and 3